Clinical Trial Update: Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of Velcade (bortezomib) in combination with irinotecan for advanced cervical, vulvar, or vaginal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Velcade (bortezomib)

Snippet

Sponsor: Women and Infants Hospital of Rhode Island | Conditions: Cervical Cancer | Phase 2 | Status: TERMINATED